Les références en gras ont été publiées par les membres de MATHEC
2020
Immunological consequences of « immune reconstitution therapy » in multiple sclerosis: A systematic review.
Sellner J, Rommer PS.
Autoimmun Rev. 2020 Apr;19(4):102492. doi: 10.1016/j.autrev.2020.102492.
2019
Autologous Hematopoietic Stem Cell Transplantation Improves Fatigue in Multiple Sclerosis
Bose G, Atkins HL, Bowman M, Freedman MS
Mult Scler. 2019 Nov;25(13):1764-1772.doi: 10.1177/1352458518802544.
Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.
Cohen JA, Baldassari LE, Atkins HL, Bowen JD, Bredeson C, Carpenter PA, Corboy JR, Freedman MS, Griffith LM, Lowsky R, Majhail NS, Muraro PA, Nash RA, Pasquini MC, Sarantopoulos S, Savani BN, Storek J, Sullivan KM, Georges GE.
Biol Blood Marrow Transplant. 2019 May;25(5):845-854. doi: 10.1016/j.bbmt.2019.02.014.
Prospective phase II clinical trial of autologous haematopoietic stem cell transplant for treatment refractory multiple sclerosis.
Moore JJ, Massey JC, Ford CD, Khoo ML, Zaunders JJ, Hendrawan K, Barnett Y, Barnett MH, Kyle KA, Zivadinov R, Ma KC, Milliken ST, Sutton IJ, Ma DDF.
J Neurol Neurosurg Psychiatry. 2019 May;90(5):514-521. doi: 10.1136/jnnp-2018-319446.
Sustained remission in multiple sclerosis after hematopoietic stem cell transplantation.
Tolf A, Fagius J, Carlson K, Åkerfeldt T, Granberg T, Larsson EM, Burman J.
Acta Neurol Scand. 2019 Nov;140(5):320-327.
Indications de l’autogreffe de cellules souches hématopoïétiques dans la polyradiculonévrite inflammatoire démyélinisante chronique : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
Puyade M, Labeyrie C, Badoglio M, Cintas P, Guenounou S, Lansiaux P, Marjanovic Z, Nicolas G, Pomies A, Terriou L, Torregrosa Diaz JM, Baron C, Castilla Llorente C, Yakoub-Agha I, Farge D.
Bull Cancer. 2019 Dec 7. pii: S0007-4551(19)30403-5.
Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases: updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
Sharrack B, Saccardi R, Alexander T, Badoglio M, Burman J, Farge D, Greco R, Jessop H, Kazmi M, Kirgizov K, Labopin M, Mancardi G, Martin R, Moore J, Muraro PA, Rovira M, Sormani MP, Snowden JA; European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE).
Bone Marrow Transplant. 2019 Sep 26. doi: 10.1038/s41409-019-0684-0.
Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple SclerosisA Randomized Clinical Trial
Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB.
JAMA. 2019 Jan 15;321(2):165-174. doi: 10.1001/jama.2018.18743.
Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple Sclerosis.
Mehra V, Rhone E, Widya S, Zuckerman M, Potter V, Raj K, Kulasekararaj A, McLornan D, de Lavallade H, Benson-Quarm N, Lim C, Ware S, Sudhanva M, Malik O, Nicholas R, Muraro PA, Marsh J, Mufti GJ, Silber E, Pagliuca A, Kazmi MA.
Clin Infect Dis. 2019 Jan 15. pii: ciz047. doi: 10.1093/cid/ciz047.
Autologous hematopoietic cell transplantation for treatment-refractory relapsing multiple sclerosis: position statement from the American Society for Blood and Marrow Transplantation
Cohen JA, Baldassari LE, Atkins HL, Bowen JD, Bredeson C, Carpenter PA, Corboy JR, Freedman MS, Griffith LM, Lowsky R, Majhail NS, Muraro PA, Nash RA, Pasquini MC, Sarantopoulos S, Savani BN, Storek J, Sullivan KM, Georges GE.
Biol Blood Marrow Transplant. 2019 Feb 19. pii: S1083-8791(19)30139-9. doi: 10.1016/j.bbmt.2019.02.014
2018
Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis
Harris VK, Stark J, Vyshkina T, Blackshear L, Joo G, Stefanova V, Sara G, Sadiq SA.
EBioMedicine. 2018 Mar;29:23-30. doi: 10.1016/j.ebiom.2018.02.002.
[Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis].
Zephir H, Puyade M, Gueguen A, Michel L, Terriou L, Dive D, Laureys G, Mathey G, Labauge P, Marjanovic Z, Pugnet G, Badoglio M, Lansiaux P, Ibrahim YA, Béguin Y, Farge D.
Bull Cancer. 2018 Dec 4
Advising patients seeking stem cell interventions for multiple sclerosis.
von Wunster B, Bailey S, Wilkins A, Marks DI4, Scolding NJ, Rice CM
Pract Neurol. 2018 May 30
Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.
Darlington PJ, Stopnicki B, Touil T, Doucet JS, Fawaz L, Roberts ME, Boivin MN, Arbour N, Freedman MS, Atkins HL, Bar-Or A.
Front Immunol. 2018 May 7;9:834
Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Sclerosis.
Rush CA, Atkins HL, Freedman MS.
Cold Spring Harb Perspect Med. 2018 Apr 2.
Autologous haematopoietic stem cell transplantation for neurological diseases.
Burman J, Tolf A, Hägglund H, Askmark H.
J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):147-155
2017
Autologous hematopoietic stem cell transplantation for pediatric multiple sclerosis: a registry-based study of the Autoimmune Diseases Working Party (ADWP) and Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).
Burman J, Kirgizov K, Carlson K, Badoglio M, Mancardi GL, De Luca G, Casanova B, Ouyang J, Bembeeva R, Haas J, Bader P, Snowden J, Farge D.
Bone Marrow Transplant. 2017 Aug;52(8):1133-1137
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.
Casanova B, Jarque I, Gascón F, Hernández-Boluda JC, Pérez-Miralles F, de la Rubia J, Alcalá C, Sanz J, Mallada J, Cervelló A, Navarré A, Carcelén-Gadea M, Boscá I, Gil-Perotin S, Solano C, Sanz MA, Coret F.
Neurol Sci. 2017 Jul;38(7):1213-1221.
Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.
Muraro PA, Martin R, Mancardi GL, Nicholas R, Sormani MP, Saccardi R.
Nat Rev Neurol. 2017 Jun 16. doi: 10.1038/nrneurol.2017.81
Myasthenia gravis after allogeneic bone marrow transplantation: A case report and literature review.
Tsutsumi Y, Kamiishi T, Kikuchi R, Ito S, Matsuoka S, Teshima T.
Hematol Oncol Stem Cell Ther. 2017 May 18. pii: S1658-3876(17)30052-3. doi: 10.1016/j.hemonc.2017.04.001.
Selection of Patients With Multiple Sclerosis to Undergo Autologous Hematopoietic Stem Cell Transplantation.
Racke MK, Imitola J.
JAMA Neurol. 2017 Apr 1;74(4):392-394. doi: 10.1001/jamaneurol.2016.5925.
NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.
Sormani MP, Muraro PA, Saccardi R, Mancardi G.
Mult Scler. 2017 Feb;23(2):201-204. doi: 10.1177/1352458516645670.
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis.
Paolo A. Muraro, MD; Marcelo Pasquini, MD; Harold L. Atkins, MD; James D. Bowen, MD; Dominique Farge, MD; Athanasios Fassas, MD; Mark S. Freedman, MD; George E. Georges, MD; Francesca Gualandi, MD; Nelson Hamerschlak, MD; Eva Havrdova, MD; Vassilios K. Kimiskidis, MD; Tomas Kozak, MD; Giovanni L. Mancardi, MD; Luca Massacesi, MD; Daniela A. Moraes, MD; Richard A. Nash, MD; Steven Pavletic, MD; Jian Ouyang, MD; Montserrat Rovira, MD; Albert Saiz, MD; Belinda Simoes, MD; Marek Trneny, MD; Lin Zhu, MD; Manuela Badoglio, MSc; Xiaobo Zhong, MS; Maria Pia Sormani, PhD; Riccardo Saccardi, MD; for the Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group
JAMA Neurol. Published online February 20, 2017. doi:10.1001/jamaneurol.2016.5867
Autologous hematopoietic cell transplantation in multiple sclerosis.
Bell SM, Sharrack B, Snowden JA.
Expert Opin Biol Ther. 2017 Jan;17(1):77-86.
2016
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
Atkins HL, Bowman M, Allan D, Anstee G, Arnold DL, Bar-Or A, Bence-Bruckler I, Birch P, Bredeson C, Chen J, Fergusson D, Halpenny M, Hamelin L, Huebsch L, Hutton B, Laneuville P, Lapierre Y, Lee H, Martin L, McDiarmid S, O’Connor P, Ramsay T, Sabloff M, Walker L, Freedman MS.
Lancet. 2016 Aug 6;388(10044):576-85. doi: 10.1016/S0140-6736(16)30169-6.
Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.
Brändle SM, Obermeier B, Senel M, Bruder J, Mentele R, Khademi M, Olsson T, Tumani H, Kristoferitsch W, Lottspeich F, Wekerle H, Hohlfeld R, Dornmair K.
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7864-9. doi: 10.1073/pnas.1522730113.
Antibodies in multiple sclerosis oligoclonal bands target debris.
Winger RC, Zamvil SS.
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7696-8. doi: 10.1073/pnas.1609246113.
Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.
Bryant A, Atkins H, Pringle CE, Allan D, Anstee G, Bence-Bruckler I, Hamelin L, Hodgins M, Hopkins H, Huebsch L, McDiarmid S, Sabloff M, Sheppard D, Tay J, Bredeson C.
JAMA Neurol. 2016 Jun 1;73(6):652-8. doi: 10.1001/jamaneurol.2016.0113
2015
Autologous hematopoietic stem cell transplantation in multiple sclerosis: a phase II trial.
Mancardi GL, Sormani MP, Gualandi F, Saiz A, Carreras E, Merelli E, Donelli A, Lugaresi A, Di Bartolomeo P, Rottoli MR, Rambaldi A, Amato MP, Massacesi L, Di Gioia M, Vuolo L, Currò D, Roccatagliata L, Filippi M, Aguglia U, Iacopino P, Farge D, Saccardi R; ASTIMS Haemato-Neurological Collaborative Group, On behalf of the Autoimmune Disease Working Party (ADWP) of the European Group for Blood and Marrow Transplantation (EBMT); ASTIMS Haemato-Neurological Collaborative Group On behalf of the Autoimmune Disease Working Party ADWP of the European Group for Blood and Marrow Transplantation EBMT.
Neurology. 2015 Mar 10;84(10):981-8. doi: 10.1212/WNL.0000000000001329.
Autologous hematopoietic stem cell transplantation in neuromyelitis optica: a registry study of the EBMT Autoimmune Diseases Working Party.
Greco R, Bondanza A, Oliveira MC, Badoglio M, Burman J, Piehl F, Hagglund H, Krasulova E, Simões BP, Carlson K, Pohlreich D, Labopin M, Saccardi R, Comi G, Mancardi GL, Bacigalupo A, Ciceri F, Farge D.
Mult Scler. 2015 Feb;21(2):189-97. doi: 10.1177/1352458514541978.
2014
Autologous haematopoietic stem cell transplantation: a viable treatment option for CIDP.
Press R, Askmark H, Svenningsson A, Andersen O, Axelson HW, Strömberg U, Wahlin A, Isaksson C, Johansson JE, Hägglund H.
J Neurol Neurosurg Psychiatry. 2014 Jun;85(6):618-24
2012
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
Saccardi R, Freedman MS, Sormani MP, Atkins H, Farge D, Griffith LM, Kraft G, Mancardi GL, Nash R, Pasquini M, Martin R, Muraro PA; European Blood and Marrow Transplantation Group; Center for International Blood and Marrow Research; HSCT in MS International Study Group.
Mult Scler. 2012 Jun;18(6):825-34. doi: 10.1177/1352458512438454.
Autologous hematopoietic stem cell transplantation for multiple sclerosis–if confused or hesitant, remember: ‘treat with standard immune suppressive drugs and if no inflammation, no response.
Burt RK, Balabanov R, Voltarelli J, Barreira A, Burman J.
Mult Scler. 2012 Jun;18(6):772-5. doi: 10.1177/1352458512442993.
2010
Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.
Pasquini MC, Griffith LM, Arnold DL, Atkins HL, Bowen JD, Chen JT, Freedman MS, Kraft GH, Mancardi GL, Martin R, Muraro PA, Nash RA, Racke MK, Storek J, Saccardi R.
Biol Blood Marrow Transplant. 2010 Aug;16(8):1076-83. doi: 10.1016/j.bbmt.2010.03.012.
New onset of myasthenia gravis after treatment of systemic sclerosis by autologous hematopoietic stem cell transplantation: sustained autoimmunity or inadequate reset of tolerance?
Deligny C, Clave E, Sibon D, Daikeler T, Keshmandt H, Carmagnat M, Douay C, Arfi S, Clair B, Toubert A, Farge D.
Hum Immunol. 2010 Apr;71(4):363-5. doi: 10.1016/j.humimm.2010.01.013.
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis.
Tappenden P, Saccardi R, Confavreux C, Sharrack B, Muraro PA, Mancardi GL, Kozak T, Farge-Bancel D, Madan J, Rafia R, Akehurst R, Snowden J.
Bone Marrow Transplant. 2010 Jun;45(6):1014-21. doi: 10.1038/bmt.2009.305.
2008
Autologous haematopoietic stem-cell transplantation in multiple sclerosis.
Mancardi G, Saccardi R.
Lancet Neurol. 2008 Jul;7(7):626-36. doi: 10.1016/S1474-4422(08)70138-8.
Immunoablation and autologous hematopoietic stem cell transplantation (AHSCT) in multiple sclerosis.
Créange A, Farge-Bancel D.
Rev Neurol (Paris). 2008 Mar;164(3):207-15. doi: 10.1016/j.neurol.2007.10.001.
2004
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis.
Saccardi R, Tyndall A, Coghlan P, Denton C, Edan G, Emdin M, Farge D et al.
Bone Marrow Transplant. 2004 Nov;34(10):877-81.